Reports
Sale
Global Anaemia Drugs Market Size, Share, Trends, Forecast: By Anaemia Type: Iron Deficiency, CKD (Chronic Kidney Disease), Sickle Cell, Aplastic, Others; By Drugs: Dietary Supplements, Medicines; By Distribution Channel: Hospital Pharmacy, Store Pharmacy, Online, Others; Regional Analysis; Market Dynamics; Competitive Landscape; 2024-2032
Global Anaemia Drugs Market Outlook
The global anaemia drugs market is expected to grow at a CAGR of 8% in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increase in Kidney Diseases to Aid the Market Growth of Anaemia Drugs
The market growth of anaemia drugs is being driven by the significant contribution by North America to the global market. This could be attributed to the increase in incidence of the condition, increase in kidney diseases, and unhealthy lifestyle across the region. In addition, rise in health care expenditure, high research activities, advanced technology, and increasing awareness about anaemia are predicted to bolster the anaemia drugs industry in the region. Europe is expected to follow North America, in terms of contribution to the overall market growth. The market in the Asia Pacific is predicted to grow rapidly over the forecast period as the result of rising healthcare expenditure, surge in disposable income, rise in geriatric population, increase in awareness, high prevalence of chronic diseases, and complications during pregnancy in many developing countries.
Anaemia Drugs: Market Segmentation
Anaemia is a medical condition in which red blood cell (RBC) count or haemoglobin is less than normal. Anaemia results in shortness of breath, fatigue, palpitations, and dizziness. Anaemic drugs are used in the treatment of this condition.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of anaemia type, the market is divided into:
- Iron Deficiency
- CKD (Chronic Kidney Disease)
- Sickle Cell
- Aplastic
- Others
Based on drugs, the industry can be segmented into:
- Dietary Supplements
- Medicines
The dietary supplements are further divided on the basis of types into iron supplements and vitamin supplements, among others, whereas medicines are further divided into antibiotics, hormones (erythropoietin), chelation therapy (lead poisoning), among others.
By distribution channel, the industry is categorised into:
- Hospital Pharmacy
- Store Pharmacy
- Online
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising Prevalence of Anaemia to Aid the Market Growth of Anaemia Drugs
The market growth of anaemia drugs is being driven by the rising prevalence of this condition in children and women. In addition, factors such as unhealthy lifestyle, high number of women of reproductive age, development of pipeline products, and complications during pregnancy, especially in developing countries are expected to provide impetus over the forecast period. Further, rise in geriatric population, enhancing healthcare infrastructure, and rapid R&D are expected to fuel the market growth over the forecast period. However, factors like lack of awareness about health in many developing countries and expensive drugs are anticipated to hinder the market growth of anaemia drugs over the forecast period.
Key Industry Players in the Global Anaemia Drugs Market
The report gives a detailed analysis of the following key players in the global anaemia drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Amgen Inc.
- Pieris Pharmaceuticals, Inc.
- Pfizer Inc.
- Akebia Therapeutics, Inc.
- Takeda Pharmaceutical Company Limited
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Anaemia Type |
|
| Breakup by Drugs |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Anaemia Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Anaemia Drugs Historical Market (2018-2023)
8.3 Global Anaemia Drugs Market Forecast (2024-2032)
8.4 Global Anaemia Drugs Market by Anaemia Type
8.4.1 Iron Deficiency
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 CKD (Chronic Kidney Disease)
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Sickle Cell
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.4 Aplastic
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.5 Others
8.5 Global Anaemia Drugs Market by Drugs
8.5.1 Dietary Supplements
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.1.3 Breakup by Type
8.5.1.3.1 Iron supplements
8.5.1.3.1.1 Historical Trend (2018-2023)
8.5.1.3.1.2 Forecast Trend (2024-2032)
8.5.1.3.2 Vitamin supplements
8.5.1.3.2.1 Historical Trend (2018-2023)
8.5.1.3.2.2 Forecast Trend (2024-2032)
8.5.1.3.3 Others
8.5.2 Medicines
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.2.3 Breakup by Type
8.5.2.3.1 Antibiotics
8.5.2.3.1.1 Historical Trend (2018-2023)
8.5.2.3.1.2 Forecast Trend (2024-2032)
8.5.2.3.2 Hormones (Erythropoietin)
8.5.2.3.2.1 Historical Trend (2018-2023)
8.5.2.3.2.2 Forecast Trend (2024-2032)
8.5.2.3.3 Chelation Therapy (Lead Poisoning)
8.5.2.3.3.1 Historical Trend (2018-2023)
8.5.2.3.3.2 Forecast Trend (2024-2032)
8.5.2.3.4 Others
8.6 Global Anaemia Drugs Market by Distribution Channel
8.6.1 Hospital Pharmacy
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Store Pharmacy
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Online
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Others
8.7 Global Anaemia Drugs Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2023)
8.7.5.2 Forecast Trend (2024-2032)
9 North America Anaemia Drugs Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Anaemia Drugs Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Anaemia Drugs Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Anaemia Drugs Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Anaemia Drugs Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Amgen Inc.
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Pieris Pharmaceuticals, Inc.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Pfizer Inc.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Akebia Therapeutics, Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Takeda Pharmaceutical Company Limited
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Anaemia Drugs Market: Key Industry Highlights, 2015 and 2025
2. Global Anaemia Drugs Historical Market: Breakup by Anaemia Type (USD Billion), 2018-2023
3. Global Anaemia Drugs Market Forecast: Breakup by Anaemia Type (USD Billion), 2024-2032
4. Global Anaemia Drugs Historical Market: Breakup by Drugs (USD Billion), 2018-2023
5. Global Anaemia Drugs Market Forecast: Breakup by Drugs (USD Billion), 2024-2032
6. Global Anaemia Drugs Historical Market: Breakup by Distribution Channel (USD Billion), 2018-2023
7. Global Anaemia Drugs Market Forecast: Breakup by Distribution Channel (USD Billion), 2024-2032
8. Global Anaemia Drugs Historical Market: Breakup by Region (USD Billion), 2018-2023
9. Global Anaemia Drugs Market Forecast: Breakup by Region (USD Billion), 2024-2032
10. North America Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2023
11. North America Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2024-2032
12. Europe Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2023
13. Europe Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2024-2032
14. Asia Pacific Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2023
15. Asia Pacific Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2024-2032
16. Latin America Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2023
17. Latin America Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2024-2032
18. Middle East and Africa Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2018-2023
19. Middle East and Africa Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2024-2032
20. Global Anaemia Drugs Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 8% between 2024 and 2032.
The major drivers of the market include rising prevalence of anaemia and increasing geriatric population.
The key trends guiding the growth of the market include the enhancing healthcare infrastructure and rapid research and development.
The major regions in the market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading anaemia types in the market report are iron deficiency, CKD (chronic kidney disease), sickle cell, and aplastic, among others.
The major drugs in the market are dietary supplements and medicines.
The significant distribution channels in the market are hospital pharmacy, store pharmacy, and online, among others.
The major players in the global anaemia drugs market are Amgen Inc., Pieris Pharmaceuticals, Inc., Pfizer Inc., Akebia Therapeutics, Inc., and Takeda Pharmaceutical Company Limited, among others.
Analyst Review
The global anaemia drugs market is being driven by the rising geriatric population. Aided by the growing R&D activities, the market is expected to witness a healthy growth in the forecast period of 2024-2032, growing at a CAGR of 8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By anaemia type, the market is segmented into iron deficiency, CKD (chronic kidney disease), sickle cell, and aplastic, among others. On the basis of drugs, the industry is bifurcated into dietary supplements and medicines. Based on distribution channel, the market is divided into hospital pharmacy, store pharmacy, and online, among others. The major regional markets for anaemia drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Amgen Inc., Pieris Pharmaceuticals, Inc., Pfizer Inc., Akebia Therapeutics, Inc., and Takeda Pharmaceutical Company Limited, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER